James Christensen

2014

In 2014, James Christensen earned a total compensation of $1.3M as Senior Vice President and Chief Scientific Officer at Mirati Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$55,800
Option Awards$915,394
Salary$319,154
Other$2,975
Total$1,293,323

Christensen received $915.4K in option awards, accounting for 71% of the total pay in 2014.

Christensen also received $55.8K in non-equity incentive plan, $319.2K in salary and $3K in other compensation.

Rankings

In 2014, James Christensen's compensation ranked 6,432nd out of 13,032 executives tracked by ExecPay. In other words, Christensen earned more than 50.6% of executives.

ClassificationRankingPercentile
All
6,432
out of 13,032
51st
Division
Manufacturing
2,345
out of 4,965
53rd
Major group
Chemicals And Allied Products
786
out of 1,690
54th
Industry group
Drugs
615
out of 1,369
55th
Industry
Pharmaceutical Preparations
468
out of 1,042
55th
Source: SEC filing on April 23, 2015.

Christensen's colleagues

We found two more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2014.

2014

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2014

Mark Gergen

Mirati Therapeutics

Executive Vice President and Chief Operations Officer

News

In-depth

You may also like